Safety and effectiveness of RBD-specific polyclonal equine F(ab´)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study.
Farizano Salazar DH, Achinelli F, Colonna M, Pérez L, Giménez AA, Ojeda MA, Miranda Puente SN, Sánchez Negrette L, Cañete F, Martelotte Ibarra OI, Sanguineti S, Spatz L, Goldbaum FA, Massa C, Rivas M, Pichel M, Hiriart Y, Zylberman V, Gallego S, Konigheim B, Fernández F, Deprati M, Roubicek I, Giunta DH, Nannini E, Lopardo G, Belloso WH; EPIC Study Group.
Farizano Salazar DH, et al. Among authors: zylberman v.
PLoS One. 2022 Sep 26;17(9):e0274796. doi: 10.1371/journal.pone.0274796. eCollection 2022.
PLoS One. 2022.
PMID: 36155545
Free PMC article.